"We will expand adoption of the real-time inpatient monitoring system 'thynC' to more than 100,000 beds and achieve annual digital health care sales exceeding 300 billion won."
Park Hyeong-cheol, head of Daewoong Pharmaceutical’s ETC marketing division, made the remarks on the 23rd at a “digital health care vision” media briefing in Seoul. He also said the company aims to establish a nationwide monitoring system that can support patients at home after discharge.
On the sales target, Park said the market size can vary depending on how digital health care is defined, but added he believes the goal is achievable even when counting only products already in use by medical staff.
Daewoong Pharmaceutical, which set up a dedicated digital health care organization in 2024, unveiled its upgraded next-generation artificial intelligence health care platform, “ALL New thynC,” at the event. The platform integrates patient health data by linking biometric information collected from wearable sensors — including electrocardiograms, blood pressure and oxygen saturation — with tools such as continuous glucose monitoring, ring-type continuous blood pressure monitoring and an AI voice-recognition medical record solution.
Executives from partner companies, including Seers Technology, iCoop, Sky Labs and Puzzle AI, attended the briefing to share the platform’s technical value and examples of use in clinical settings. iCoop’s continuous glucose monitoring solution, CGM Live, tracks real-time blood sugar changes in hospitalized patients. Sky Labs’ ring-type continuous blood pressure monitoring solution, Cart On, automatically measures and records blood pressure. Puzzle AI’s AI voice-recognition solution, CL Note, recognizes clinicians’ speech in real time and links it to electronic medical records.
Lee Young-shin, CEO of Seers Technology, said ALL New thynC is evolving into an AI-based platform that supports clinicians’ decision-making and will expand beyond in-hospital monitoring to home care to broaden full-cycle patient monitoring.
The briefing also cited a case in which an early warning alert detected by thynC in a real-world medical setting helped identify a patient just before cardiac arrest. Daewoong Pharmaceutical said it plans to further advance monitoring technology so care does not stop outside the hospital.
Park said the value lies in connecting technologies through an integrated platform to support clinical decisions, adding the company will continue working with partners across more medical settings.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.